SPRY vs W · rev $89.1M vs rev $11.85B
ARS Pharmaceuticals, Inc (SPRY) versus Wayfair Inc (W) — a side-by-side from cached financials, not a winner call.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Wayfair Inc (W) is a internet retail company listed on NYSE.
Latest reported SPRY revenue for 2024-12-31 was $89.1M. Net income was $8.0M. Revenue was up 297063.3% from 2023-12-31 to 2024-12-31. SPRY currently screens at market cap $983.1M.
Latest reported W revenue for 2024-12-31 was $11.85B. Net income was -$492.0M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. W currently screens at market cap $10.77B.
SPRY currently screens at market cap $983.1M. W currently screens at market cap $10.77B.
Not investment advice. Open the SPRY and W stock pages for the full models.
Not investment advice.